XSHE
300253
Market cap2.27bUSD
Oct 09, Last price
7.24CNY
1D
4.78%
1Q
1.54%
Jan 2017
-29.78%
IPO
57.73%
Name
Winning Health Technology Group Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Winning Health Technology Group Co., Ltd. specializes in delivering comprehensive information technology solutions to hospitals and various medical service organizations throughout China. Their services cover the entire lifecycle of IT provision, from initial design, planning, and strategic consulting to development, system deployment, ongoing maintenance, and operational management. These advanced solutions are instrumental in establishing intelligent hospital environments, as well as powering regional, community, and public healthcare oversight platforms, medical insurance systems, and a broad spectrum of other health services. Founded in Shanghai, China, in 1994, the company was initially known as Shanghai Kingstar Winning Software Co., Ltd. before officially adopting its current name in January 2016.
Key people
Tao Wang
President, Director · since 2018
Li Wang
Chief Financial Officer · since 2018
Jiaming Sun
Senior Vice President · since 2018
Zitong Xu
Senior Vice President, Secretary of the Board · since 2024
Mao Jin
Senior Vice President, Director · since 2024
Ning Liu
Chairman of the Board, Staff Elected Director · since 2025
Cheng Zhou
Vice Chairman of the Board · since 2025
Independent Director · since 2021
Weisong Wang
Independent Director · since 2021
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||